First FDA-approved drug containing marijuana extract goes on sale in U.S.

THURSDAY, Nov.1, 2018 — The first Food and Drug Administration-approved drug containing an ingredient derived from the marijuana plant went on sale Thursday in the United States.

Epidiolex is a twice-daily oral solution — a cannabidiol, or CBD liquid — made by Britain-based GW Pharmaceuticals. It is approved for use in patients 2 years old and older with two types of epileptic syndromes, Dravet syndrome and Lennox-Gastaut syndrome.

“Because these patients have historically not responded well to available seizure medications, there has been a dire need for new therapies that aim to reduce the frequency and impact of seizures,” Justin Gover, CEO of GW Pharmaceuticals, said in a written statement.

The FDA approved Epidiolex in June. CBD is derived from the cannabis plant but it does not create any “high” in users. CBD oils and other CBD products have become popular across the United States

... read more at: https://www.upi.com/Health_News/2018/11/01/First-FDA-approved-drug-containing-marijuana-extract-goes-on-sale-in-US/2781541097273/

by